Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Therapure Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10923
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Therapure Biopharma Inc (Therapure) is a biotherapeutics company that enhances patient care through its three divisions: therapure biomanufacturing, therapure innovations and evolve biologics. The company’s therapure biomanufacturing division offers pipeline products such as TBI 301, TBI 302 and TBI 304H. Its company’s therapure innovations operate as a proprietary drug development division and uses proprietary protein technologies for the treatment of diseases such as anemia, liver cancer, and hepatitis C. Therapure’s services include purification, development, manufacture, and packaging of therapeutic proteins and follow-on biologics. The company operates through bio-pharmaceutical companies in across the world. Therapure is headquartered in Mississauga, Ontario, Canada.

Therapure Biopharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Therapure Biopharma To Acquire Plasma Protein Purification Technology From Upfront Chromatography 10
Private Equity 12
Catalyst Capital Group May Sell Therapure Biopharma for USD300 Million 12
Equity Offering 13
Therapure Biopharma Postpones IPO 13
Asset Transactions 14
10363782 Canada to Acquire CDMO Business from Therapure Biopharma for USD290 Million 14
Therapure Biopharma Inc – Key Competitors 15
Therapure Biopharma Inc – Key Employees 16
Therapure Biopharma Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 23, 2018: Therapure Biopharma Launches Biologics Division as Evolve Biologics, an Innovative Plasma-Derived Therapeutics Company 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Therapure Biopharma To Acquire Plasma Protein Purification Technology From Upfront Chromatography 10
Catalyst Capital Group May Sell Therapure Biopharma for USD300 Million 12
Therapure Biopharma Postpones IPO 13
10363782 Canada to Acquire CDMO Business from Therapure Biopharma for USD290 Million 14
Therapure Biopharma Inc, Key Competitors 15
Therapure Biopharma Inc, Key Employees 16
Therapure Biopharma Inc, Other Locations 17

List of Figures
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapure Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • President Energy PLC (PPC):企業の財務・戦略的SWOT分析
    President Energy PLC (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Petroleo Brasileiro S.A. (Petrobras):企業のM&A・事業提携・投資動向
    Petroleo Brasileiro S.A. (Petrobras) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Petroleo Brasileiro S.A. (Petrobras) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Kadimastem Ltd (KDST):製薬・医療:M&Aディール及び事業提携情報
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Nobel Biocare Holding AG:企業のM&A・提携動向(医療機器分野)
    Summary Nobel Biocare Holding AG (Nobel Biocare), a subsidiary of Danaher Corporation, is a medical device company. The company carries out development, manufacturing and marketing of implant-based dental restorations, high-precision individualized prosthetics, CAD/CAM systems, diagnostics, treatmen …
  • MDNA Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. …
  • 2G Energy AG (2GB):企業の財務及び戦略的SWOT分析
    Summary 2G Energy AG (2G Energy) is an energy service provider that designs and manufactures combined heat and power (CHP) modules. The company offers biogas modules that include G-box, agenitor, avus, filius, and 2G KWK-Series. It also offers installation options like container, indoor housing, con …
  • E-Ton Solar Tech. Co., LTD. (3452):企業の財務及び戦略的SWOT分析
    Summary E-Ton Solar Tech. Co., LTD. (E-Ton Solar) a subsidiary of the Inventec Group, is a solar cell manufacturer that develops and manufactures solar cells and energy solutions. The company’s products include ExcelTon II series and ExcelTon III series. E-Ton Solar series offers monocrystalline, mu …
  • Medtronic Advanced Energy:企業のM&A・提携動向(医療機器分野)
    Summary Medtronic Advanced Energy (MAE), a subsidiary of Medtronic plc is a medical device company that manufactures, develops, markets and sells advanced energy devices used in surgical procedures. The company offers products through divisions such as aquamantys products and PEAK plasmablade produc …
  • Aspiro AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aspiro AB Mergers and Acquisiti …
  • Donlinks International Investment Co., Ltd:企業の戦略・SWOT・財務分析
    SummaryDonlinks International Investment Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view …
  • Evogene Ltd. (EVGN):企業の財務及び戦略的SWOT分析
    Summary Evogene Ltd. (Evogene) is a plant genomics company that offers solutions for crop production improvement through advanced breeding. The company focuses on developing biotechnology and advanced breeding improved traits for crops that feed the world, including corn, soybean, cotton, canola, ri …
  • Nobilis Health Corp. (formerly Northstar Healthcare, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nobilis Health Corp. (formerly …
  • Activision Blizzard, Inc.の企業概要及び財務/SWOT分析
    Activision Blizzard, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quart …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務分析
    SummaryThe Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Unilever Ghana Limited:企業の戦略・SWOT・財務分析
    Unilever Ghana Limited - Strategy, SWOT and Corporate Finance Report Summary Unilever Ghana Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Colexon Energy AG (HRPK):企業概要、財務及び戦略的SWOT分析
    Summary Colexon Energy AG (Colexon ) is a renewable energy company. The company develops large-scale photovoltaic system. It offers a wide range of solar modules and components from manufacturers as well as solutions for photovoltaic systems. Colexon offers tailored solutions for photovoltaic system …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Therapure Biopharma, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Therapure Biopharma, Inc. Merge …
  • Strides Shasun Limited:企業のM&A・事業提携・投資動向
    Strides Shasun Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Strides Shasun Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆